Delivery Order SPE2DB20D3103-SPE2DB25FQ4G3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,938.52 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is scheduled for completion by August 4, 2025, with performance at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,920.02 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This contract, designated as a firm fixed price delivery order with no set-aside provisions, was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $64,621.77 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) on September 26, 2025, with completion expected by September 29, 2025. This contract employs firm fixed-price pricing under a non-competitive, non-set-aside arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $18,664.07 delivery order to AmerisourceBergen Drug Corp for Ondansetron HCL 4 mg tablets (30-count units) with a completion date of September 11, 2025. This competitive award, issued as a firm fixed-price delivery order with no set-aside designation, represents a single transaction under AmerisourceBergen's larger contract vehicle with the agency. The pharmaceutical product will be delivered to the company's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,047.25 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging). This competitive award, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $47,238.51 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This competitively awarded, firm fixed-price contract was executed on September 9, 2025, with completion targeted for September 10, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,882.56 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded and completed on August 8, 2025. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,430.80 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,736.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ4G3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $52,392.08 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract. The award, made on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a competitive procurement with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare systems. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of medications and medical supplies to support Department of Defense healthcare operations. The ondansetron tablets being procured under this delivery order are anti-nausea medications commonly used in military medical and surgical settings. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains, with the DLA Troop Support Medical prime vendor contract enabling flexible sourcing of both brand-name and generic drugs to support military personnel worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.4k | 9/22/25 |